QUANTITATIVE-ANALYSIS OF ANTIATHEROSCLEROTIC EFFECT OF NIFEDIPINE IN CHOLESTEROL-FED RABBITS

被引:4
作者
OHTA, Y
HIGUCHI, N
EMURA, S
TAKASHIMA, T
OOGUSHI, K
KATO, H
OHMORI, K
SUNAGA, T
机构
[1] Department of Internal Medicine, Saga Medical School, Saga
关键词
ATHEROSCLEROSIS; NIFEDIPINE; CHOLESTEROL; COMPETITIVE INHIBITION; RABBIT;
D O I
10.1007/BF02018311
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reports concerning the effect of slow calcium-channel blockers on experimental atherosclerosis are controversial. We examined the antiatherosclerotic effect of nifedipine (40 mg/day for 16 weeks) on aorta of rabbits on diets containing 0.3%, 0.5%, and 1.0% cholesterol. There were no significant differences in levels of serum lipids with or without nifedipine in the same cholesterol-fed rabbits. The results obtained show that nifedipine suppressed the extent of lipid deposition and surface involvement (S.I.) in aorta in 0.3% cholesterol-fed rabbits, whereas nifedipine only tended to suppress S.I. in 0.5% cholesterol-fed rabbits and had no effect in 1.0% cholesterol-fed rabbits. The log dose-response relationship of S.I. was obtained by plotting the concentration of cholesterol in the feed or the "integrated value" of the total serum cholesterol (TC), i.e., the cumulative sum of the serum TC values obtained at each week. The log dose-response curve was shifted in parallel with the right in nifedipine groups. The Lineweaver-Burk plot constructed from the dose-response curve had the same points crossing the ordinate with or without nifedipine. These results suggested that nifedipine suppressed S.I. in a competitive manner with cholesterol on the specific binding site of lipid deposition. Electron-microscopic findings also demonstrated that fat droplets in smooth muscle cells, extracellular matrix containing collagen, and elastic fibers decreased in nifedipine-treated rabbits.
引用
收藏
页码:1021 / 1026
页数:6
相关论文
共 31 条
[1]  
Rosenblum I.Y., Flora L., Eisenstein R., The effect of disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis, Atherosclerosis, 22, pp. 411-424, (1975)
[2]  
Krach D.M., Aspen A.J., Apstein C.S., Suppression of experimental atherosclerosis by the Ca<sup>++</sup>-antagonist lanthanum. Possible role of calcium in atherogenesis, J Clin Invest., 65, pp. 967-981, (1980)
[3]  
Krach D.M., Aspen A.J., Rozler L.J., Atherosclerosis: Prevention by agents not affecting abnormal levels of blood lipids, Science, 213, pp. 1511-1512, (1981)
[4]  
Robert L., Brechemier D., Godeau G., Et al., Prevention of experimental immune arteriosclerosis by calcitonin, Biochem Pharmacol, 26, pp. 2129-2135, (1977)
[5]  
Henry P.D., Bentley K.I., Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine, J clin Invest, 68, pp. 1366-1369, (1981)
[6]  
Willis A.L., Nagel B., Churchill V., Et al., Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits, Arteriosclerosis, 5, pp. 250-255, (1985)
[7]  
Rouleau J.L., Parmley W.W., Stevens F.J., Et al., Verapamil suppresses atherosclerosis in cholesterol-fed rabbits, J Am Coll Cardiol, 1, pp. 1453-1466, (1983)
[8]  
Blumlein S.L., Sievers R., Kidd P., Parmley W.W., Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit, Am J Cardiol, 54, pp. 884-889, (1984)
[9]  
Stender S., Ravn H., Haugegaard M., Kjeldsen K., Effect of verapamil on accumulation of free and esterified cholesterol in the thoracic aorta of cholesterol-fed rabbits, Atherosclerosis, 61, pp. 15-23, (1986)
[10]  
Sievers R.E., Rashid T., Garret J., Et al., Verapamil and diet halt progression of atherosclerosis, in cholesterol fed rabbits, Cardiovasc Drugs Ther, 1, pp. 65-69, (1987)